Shenzhen - Delayed Quote CNY

Ningbo David Medical Device Co., Ltd. (300314.SZ)

12.39
-0.01
(-0.08%)
At close: May 16 at 3:04:49 PM GMT+8
Loading Chart for 300314.SZ
  • Previous Close 12.40
  • Open 12.40
  • Bid 12.39 x --
  • Ask 12.40 x --
  • Day's Range 12.23 - 12.46
  • 52 Week Range 9.05 - 15.55
  • Volume 6,141,700
  • Avg. Volume 9,045,846
  • Market Cap (intraday) 3.568B
  • Beta (5Y Monthly) 0.31
  • PE Ratio (TTM) 82.60
  • EPS (TTM) 0.15
  • Earnings Date --
  • Forward Dividend & Yield 0.18 (1.45%)
  • Ex-Dividend Date Jun 19, 2024
  • 1y Target Est --

Ningbo David Medical Device Co., Ltd. engages in the research and development, production, and distribution of medical equipment worldwide. The company provides infant incubators, transport incubators, infant radiant warmers, neonate bilirubin phototherapy equipment, infant resuscitators, etc. It also offers other products, such as infusion pumps, transcutaneous jaundice detectors, infant t-piece resuscitators, air/oxygen blenders, low pressure aspirators, and infant oxygen hoods. The company offers its products under David brand name. Ningbo David Medical Device Co., Ltd. was founded in 1992 and is headquartered in Ningbo, China.

www.nbdavid.com

916

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 300314.SZ

View More

Performance Overview: 300314.SZ

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

300314.SZ
10.04%
SSE Composite Index (000001.SS)
0.47%

1-Year Return

300314.SZ
3.18%
SSE Composite Index (000001.SS)
7.85%

3-Year Return

300314.SZ
25.67%
SSE Composite Index (000001.SS)
9.56%

5-Year Return

300314.SZ
19.26%
SSE Composite Index (000001.SS)
17.40%

Compare To: 300314.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 300314.SZ

View More

Valuation Measures

Annual
As of 5/16/2025
  • Market Cap

    3.57B

  • Enterprise Value

    2.95B

  • Trailing P/E

    84.80

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.20

  • Price/Book (mrq)

    2.99

  • Enterprise Value/Revenue

    5.99

  • Enterprise Value/EBITDA

    64.69

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.47%

  • Return on Assets (ttm)

    1.56%

  • Return on Equity (ttm)

    3.49%

  • Revenue (ttm)

    492.86M

  • Net Income Avi to Common (ttm)

    41.72M

  • Diluted EPS (ttm)

    0.15

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    627.36M

  • Total Debt/Equity (mrq)

    0.75%

  • Levered Free Cash Flow (ttm)

    -58.94M

Research Analysis: 300314.SZ

View More

Company Insights: 300314.SZ

Research Reports: 300314.SZ

View More

People Also Watch